Clinical Trial Update: Effects of Vildagliptin Versus Glibenclamide on Glycemia After Exercise in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial comparing the effects of vildagliptin versus glibenclamide on glycemic response after exercise in adults with Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Galvus (vildagliptin)
• Glibenclamide (glibenclamide)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Diabetes Mellitus, Type 2, Hypoglycemic Agents | Phase 4 | Status: UNKNOWN